Check-Cap Ltd. is a clinical stage medical diagnostics company engaging in the development of ingestible imaging capsule system for colorectal cancer screening.
Net Income $-13,840,000, but an encouraging Quick Ratio of 3.69.
Looking at the volume, this asset can double its price is seconds.
on 5/28/2020 HC Wainwright Reiterated Chek Rating to Buy and the target...
Entry. $0.69
S/L $0.60
TP $0.92
12 months Consensus Price Target: $3
if you find my charts useful, please leave me "like" or "comment".
Please don't trade according to the ideas, rely on your own knowledge.
Thx
